Organoid News Volume 2.25 | Jul 8 2021

    0
    41







    2021-07-08 | ON 2.25


    Organoid News by STEMCELL Technologies
    Vol. 2.25 – 8 July, 2021
    TOP STORY

    Reconstructing Single-Cell Karyotype Alterations in Colorectal Cancer Identifies Punctuated and Gradual Diversification Patterns

    Using patient-derived colorectal cancer organoids and fresh tumor biopsies, the authors demonstrated that karyotype alterations of varying complexity were prevalent and could arise within a few cell generations.
    [Nature Genetics]

    Full Article
    Scientific resources to support your organoids research. Learn More!
    PUBLICATIONSRanked by the impact factor of the journal

    MIR21-Induced Loss of Junctional Adhesion Molecule A Promotes Activation of Oncogenic Pathways, Progression and Metastasis in Colorectal Cancer

    Using junctional adhesion molecules (JAM)-A knockdown, re-expression and rescue experiments in cell line monolayers, 3D spheroids, patient-derived organoids and xenotransplants, researchers demonstrated that JAM-A silencing promoted proliferation and migration in 2D and 3D cell models and increased tumor volume and metastases in vivo.
    [Cell Death & Differentiation]

    Full Article

    Coculture of Primary Human Colon Monolayer with Human Gut Bacteria

    The authors described a protocol that could be used to coculture a primary human colon monolayer with aerotolerant bacteria. Primary human colon cells maintained as organoids were dispersed into single-cell suspensions and then seeded on collagen-coated Transwell inserts, where they attached and proliferated to form confluent monolayers within days of seeding.
    [Nature Protocols]

    Abstract

    Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study

    Patient tumor organoids were fabricated using unsorted tumor cells with and without enrichment with patient matched immune components derived from peripheral blood leukocytes, spleen, or lymph nodes.
    [Clinical Cancer Research]

    Abstract

    Active Elimination of Intestinal Cells Drives Oncogenic Growth in Organoids

    Scientists showed that cancer cells used competitive cell interactions to actively eliminate wild-type intestine cells in enteroid monolayers and organoids. This apoptosis-dependent process boosted proliferation of intestinal cancer cells.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Kras Activation in Endometrial Organoids Drives Cellular Transformation and Epithelial-Mesenchymal Transition

    Investigators found that in KrasG12D-expressing endometrial organoids, Pten knockdown did not confer tumorigenicity, but Cdkn2a knockdown or Trp53 deletion led to the development of carcinosarcoma, a rare, aggressive tumor comprising both carcinoma and sarcoma.
    [Oncogenesis]

    Full Article

    Tempo-Spatial Regulation of the Wnt Pathway by FAM13A Modulates the Stemness of Alveolar Epithelial Progenitors

    Florescence-activated flow cytometry analysis, immunofluorescence and organoid culture system were performed to identify the β-catenin/Wnt-activated cells in Fam13a+/+ or Fam13a−/− mice exposed to ciagrette smoke.
    [Ebiomedicine]

    Full Article

    Identification of Cross-Reactive CD8+ T Cell Receptors with High Functional Avidity to a SARS-CoV-2 Immunodominant Epitope and Its Natural Mutant Variants

    With a predicted peptide library from SARS-CoV-2 S and N proteins, restricted to three of the most prominent HLA-A alleles in the Asian population, investigators found that specific CD8+ T cell responses were identified in over 75% of COVID-19 convalescent patients
    [Genes & Diseases]

    Abstract

    Porcine Small Intestinal Organoids as a Model to Explore ETEC–Host Interactions in the Gut

    The authors reported that porcine enteroids responded in a similar manner as in vivo gut tissues to enterotoxins derived from enterotoxigenic Escherichia coli, an enteric pathogen causing postweaning diarrhea in piglets.
    [Veterinary Research]

    Full Article

    Discovery of a Novel CDK7 Inhibitor YPN-005 in Small Cell Lung Cancer

    Investigators developed a potent inhibitor of cyclin-dependent kinase 7 (CDK7), designated YPN-005, and determined whether it showed any anticancer effects in small cell lung cancer (SCLC), cells, cisplatin or etoposide-resistant cells, or organoids derived from SCLC patients.
    [European Journal of Pharmacology]

    AbstractGraphical Abstract
    Register for a recorded organoid panel discussion moderated by Dr. James Wells
    REVIEWS

    Intestinal Multicellular Organoids to Study Colorectal Cancer

    Modeling colorectal cancer (CRC) using organoids has burgeoned in the last decade, providing enhanced in vitro models to study the development and possible treatment options for this type of cancer. The authors describe both normal and CRC intestinal organoid models and their utility in the cancer research field.
    [Biochimica et Biophysica Acta-Reviews On Cancer]

    Full Article
    INDUSTRY AND POLICY NEWS

    MIMETAS and Roche Enter into a Collaboration to Develop Human Disease Models for Drug Development

    MIMETAS, a developer of organ-on-chip-based disease models, and Roche announced that they have entered into a collaboration to develop human disease models to characterize novel compounds in inflammatory bowel disease and hepatitis B virus infections.
    [MIMETAS]

    Press Release

    $6.3 Million for Ground-Breaking Stem Cell Research Projects

    Researchers from the University of Sydney have been awarded $6.3 million for three projects which will address stem cell derived-retinal organoids for blindness in adults, iPSC derived cardiomyocytes for chronic heart failure, and help to improve decisions about access to stem cell interventions.
    [The University of Sydney]

    Press Release
    FEATURED EVENT

    11th World Congress on Alternatives and Animal Use in the Life Sciences

    August 23 – September 2, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Research Associate – Bio-Engineered Alzheimer’s Disease

    North Carolina A&T State University – Greensboro, North Carolina, United States

    PhD Student – Organotypic Models to Dissect the Cellular Crosstalk between Niche and HSPCs in Myelodysplastic Syndromes

    Georg-Speyer-Haus – Frankfurt, Germany

    Postdoctoral Fellow – Vascular Dysfunction in SARS-CoV-2

    The European Molecular Biology Laboratory – Barcelona, Spain

    Postdoctoral Researcher – Stem Cells, Organoids, and Systems Biology

    Medical College of Wisconsin – Milwaukee, Wisconsin, United States

    Postdoctoral Positions – Cellular, Molecular and Digital Medicine

    Research Center for Molecular Medicine – Vienna, Austria

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    STEMCELL Organoids Twitter